Oral gene application using chitosan-DNA nanoparticles induces transferable tolerance

Area of Science:

• Immunology
• Nanotechnology
• Vaccine Development

Background:

• Oral tolerance is a key mechanism for immune unresponsiveness to antigens.
• Tolerogenic vaccines are being explored for autoimmune diseases and allograft rejection.
• Nonviral gene transfer offers a potential strategy for inducing oral tolerance.

Purpose of the Study:

• To investigate a nonviral gene transfer strategy for oral tolerance induction.
• To evaluate antigen-encoding chitosan-DNA nanoparticles (NP) for immune modulation.
• To assess the efficacy of ovalbumin-encoding NP (OVA-NP) in inducing oral tolerance.

Main Methods:

• Chitosan-DNA nanoparticles encoding ovalbumin (OVA-NP) were developed.
• OVA-NP were administered orally to mice.
• Immune responses including delayed-type hypersensitivity (DTH), antibody formation, spleen cell proliferation, and cytokine expression were measured.
• Adoptive spleen cell transfer was used to assess the transferability of tolerance.

Main Results:

• Oral administration of OVA-NP suppressed OVA-specific DTH responses and anti-OVA antibody production.
• Spleen cell proliferation following OVA stimulation was reduced in OVA-NP treated mice.
• Cytokine profiles shifted from Th1 towards Th2/Th3 responses.
• Tolerance induced by OVA-NP was transferable and mediated by CD4(+)CD25(+) T cells.

Conclusions:

• Nonviral oral gene transfer using chitosan-DNA nanoparticles is effective in inducing antigen-specific oral tolerance.
• This strategy promotes the generation of regulatory T cells for immune modulation.
• This approach holds promise for therapeutic applications in autoimmune diseases and transplantation.